CASI Pharmaceuticals SG&A Expense (Quarterly) Analysis

CASI Pharmaceuticals Inc (CASI)

2.75 -0.04 (-1.61%) USD | NASDAQ | May 06, 16:00

2.78 +0.03 (+1.09%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1996. Upgrade now.

Date	Value
December 31, 2023	11.57M
September 30, 2023	8.039M
June 30, 2023	12.52M
March 31, 2023	9.707M
December 31, 2022	11.84M
September 30, 2022	8.415M
June 30, 2022	8.918M
March 31, 2022	8.602M
December 31, 2021	12.65M
September 30, 2021	8.692M
June 30, 2021	8.848M
March 31, 2021	8.217M
December 31, 2020	9.107M
September 30, 2020	7.409M
June 30, 2020	5.642M
March 31, 2020	5.318M
December 31, 2019	8.795M
September 30, 2019	8.952M
June 30, 2019	6.982M
March 31, 2019	5.71M
December 31, 2018	5.747M
September 30, 2018	6.905M
June 30, 2018	4.042M
March 31, 2018	1.303M
December 31, 2017	1.195M

Date	Value
September 30, 2017	0.6259M
June 30, 2017	0.6914M
March 31, 2017	0.6442M
December 31, 2016	1.418M
September 30, 2016	0.6769M
June 30, 2016	1.915M
March 31, 2016	0.7651M
December 31, 2015	0.6592M
September 30, 2015	0.6739M
June 30, 2015	0.8576M
March 31, 2015	0.9248M
December 31, 2014	0.8231M
September 30, 2014	1.150M
June 30, 2014	0.8919M
March 31, 2014	0.8914M
December 31, 2013	0.7112M
September 30, 2013	0.6626M
June 30, 2013	1.016M
March 31, 2013	0.6299M
December 31, 2012	0.5351M
September 30, 2012	0.5646M
June 30, 2012	0.6015M
March 31, 2012	1.097M
December 31, 2011	0.5219M
September 30, 2011	0.5566M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.318M

Minimum

Mar 2020

12.65M

Maximum

Dec 2021

8.959M

Average

8.795M

Median

Dec 2019

SG&A Expense (Quarterly) Benchmarks